| Majority (>50%) of patients with delirium receive … . | n = 1664 units . |
|---|---|
| Haloperidol | 768 (46.2) |
| Quetiapine | 639 (38.4) |
| Reducing of delirogenic drugs | 500 (30.0) |
| Evaluation by a specialist | 439 (26.4) |
| Lorazepama | 424 (25.5) |
| Dexmedetomidine | 401 (24.1) |
| Risperidone | 372 (22.4) |
| Melatonin | 268 (16.1) |
| Clonidine | 250 (15.0) |
| Midazolama | 231 (13.9) |
| Diazepama | 222 (13.3) |
| Beta-Blockers | 102 (6.1) |
| Melperone | 96 (5.8) |
| Levodopa | 35 (2.1) |
| Phenobarbital | 34 (2.0) |
| Distraneurin | 19 (1.1) |
| I do not know | 129 (7.8) |
| Missing data | 170 (10.2) |
| Pharmacological management … | |
| Depends on specific symptoms of each patient’s delirium | 977 (58.7) |
| Is a more individual approach, depending on patients, and side effects | 913 (54.9) |
| Is reported in handovers | 852 (51.2) |
| Is discussed with families in most cases | 574 (34.5) |
| Includes recommendations for withdrawal of delirium-related drugs | 566 (34.0) |
| Is based on a standard operation procedure/protocol | 501 (30.1) |
| Includes psychiatrist or delirium specific liaison team | 454 (27.3) |
| Is a more general approach, including a few pharmacological agents | 396 (23.8) |
| Includes pharmacologists | 342 (20.6) |
| Is discussed with patients in most cases | 310 (18.6) |
| None of the above | 50 (3.0) |
| Missing data | 67 (4.0) |
| Majority (>50%) of patients with delirium receive … . | n = 1664 units . |
|---|---|
| Haloperidol | 768 (46.2) |
| Quetiapine | 639 (38.4) |
| Reducing of delirogenic drugs | 500 (30.0) |
| Evaluation by a specialist | 439 (26.4) |
| Lorazepama | 424 (25.5) |
| Dexmedetomidine | 401 (24.1) |
| Risperidone | 372 (22.4) |
| Melatonin | 268 (16.1) |
| Clonidine | 250 (15.0) |
| Midazolama | 231 (13.9) |
| Diazepama | 222 (13.3) |
| Beta-Blockers | 102 (6.1) |
| Melperone | 96 (5.8) |
| Levodopa | 35 (2.1) |
| Phenobarbital | 34 (2.0) |
| Distraneurin | 19 (1.1) |
| I do not know | 129 (7.8) |
| Missing data | 170 (10.2) |
| Pharmacological management … | |
| Depends on specific symptoms of each patient’s delirium | 977 (58.7) |
| Is a more individual approach, depending on patients, and side effects | 913 (54.9) |
| Is reported in handovers | 852 (51.2) |
| Is discussed with families in most cases | 574 (34.5) |
| Includes recommendations for withdrawal of delirium-related drugs | 566 (34.0) |
| Is based on a standard operation procedure/protocol | 501 (30.1) |
| Includes psychiatrist or delirium specific liaison team | 454 (27.3) |
| Is a more general approach, including a few pharmacological agents | 396 (23.8) |
| Includes pharmacologists | 342 (20.6) |
| Is discussed with patients in most cases | 310 (18.6) |
| None of the above | 50 (3.0) |
| Missing data | 67 (4.0) |
This table describes the survey responses received to following questions:
(1) Do most delirious patients (≥50%) of your unit or ward receive pharmacological interventions (click all that apply)?
(2) In general, the pharmacological management on my unit or ward in delirium … (click all that apply).
aIndicates a benzodiazepine. When combined (lorazepam, midazolam and diazepam), benzodiazepines are the leading pharmacological measure reported.
| Majority (>50%) of patients with delirium receive … . | n = 1664 units . |
|---|---|
| Haloperidol | 768 (46.2) |
| Quetiapine | 639 (38.4) |
| Reducing of delirogenic drugs | 500 (30.0) |
| Evaluation by a specialist | 439 (26.4) |
| Lorazepama | 424 (25.5) |
| Dexmedetomidine | 401 (24.1) |
| Risperidone | 372 (22.4) |
| Melatonin | 268 (16.1) |
| Clonidine | 250 (15.0) |
| Midazolama | 231 (13.9) |
| Diazepama | 222 (13.3) |
| Beta-Blockers | 102 (6.1) |
| Melperone | 96 (5.8) |
| Levodopa | 35 (2.1) |
| Phenobarbital | 34 (2.0) |
| Distraneurin | 19 (1.1) |
| I do not know | 129 (7.8) |
| Missing data | 170 (10.2) |
| Pharmacological management … | |
| Depends on specific symptoms of each patient’s delirium | 977 (58.7) |
| Is a more individual approach, depending on patients, and side effects | 913 (54.9) |
| Is reported in handovers | 852 (51.2) |
| Is discussed with families in most cases | 574 (34.5) |
| Includes recommendations for withdrawal of delirium-related drugs | 566 (34.0) |
| Is based on a standard operation procedure/protocol | 501 (30.1) |
| Includes psychiatrist or delirium specific liaison team | 454 (27.3) |
| Is a more general approach, including a few pharmacological agents | 396 (23.8) |
| Includes pharmacologists | 342 (20.6) |
| Is discussed with patients in most cases | 310 (18.6) |
| None of the above | 50 (3.0) |
| Missing data | 67 (4.0) |
| Majority (>50%) of patients with delirium receive … . | n = 1664 units . |
|---|---|
| Haloperidol | 768 (46.2) |
| Quetiapine | 639 (38.4) |
| Reducing of delirogenic drugs | 500 (30.0) |
| Evaluation by a specialist | 439 (26.4) |
| Lorazepama | 424 (25.5) |
| Dexmedetomidine | 401 (24.1) |
| Risperidone | 372 (22.4) |
| Melatonin | 268 (16.1) |
| Clonidine | 250 (15.0) |
| Midazolama | 231 (13.9) |
| Diazepama | 222 (13.3) |
| Beta-Blockers | 102 (6.1) |
| Melperone | 96 (5.8) |
| Levodopa | 35 (2.1) |
| Phenobarbital | 34 (2.0) |
| Distraneurin | 19 (1.1) |
| I do not know | 129 (7.8) |
| Missing data | 170 (10.2) |
| Pharmacological management … | |
| Depends on specific symptoms of each patient’s delirium | 977 (58.7) |
| Is a more individual approach, depending on patients, and side effects | 913 (54.9) |
| Is reported in handovers | 852 (51.2) |
| Is discussed with families in most cases | 574 (34.5) |
| Includes recommendations for withdrawal of delirium-related drugs | 566 (34.0) |
| Is based on a standard operation procedure/protocol | 501 (30.1) |
| Includes psychiatrist or delirium specific liaison team | 454 (27.3) |
| Is a more general approach, including a few pharmacological agents | 396 (23.8) |
| Includes pharmacologists | 342 (20.6) |
| Is discussed with patients in most cases | 310 (18.6) |
| None of the above | 50 (3.0) |
| Missing data | 67 (4.0) |
This table describes the survey responses received to following questions:
(1) Do most delirious patients (≥50%) of your unit or ward receive pharmacological interventions (click all that apply)?
(2) In general, the pharmacological management on my unit or ward in delirium … (click all that apply).
aIndicates a benzodiazepine. When combined (lorazepam, midazolam and diazepam), benzodiazepines are the leading pharmacological measure reported.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
